Viewing Study NCT02225405


Ignite Creation Date: 2025-12-25 @ 3:24 AM
Ignite Modification Date: 2026-02-21 @ 10:30 PM
Study NCT ID: NCT02225405
Status: COMPLETED
Last Update Posted: 2024-05-08
First Post: 2014-08-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Cisplatin, Docetaxel, and Nintedanib Before Surgery in Treating Patients With Previously Untreated Stage IB-IIIA Non-small Cell Lung Cancer
Sponsor: M.D. Anderson Cancer Center
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: 2013-0844
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None NIH View